Why the study?
Does cardiac resynchronization therapy improve outcomes in patients with advanced heart failure?
Does cardiac resynchronization therapy improve outcomes in patients with advanced heart failure?
This review summarizes the rationale, evidence, and clinical indications for cardiac resynchronization therapy as an effective adjunct to conventional pharmacological therapy for advanced heart failure.
Cardiac resynchronization therapy, also known as biventricular or multi-site pacing, has been shown to be an effective adjunct to conventional pharmacological therapy for advanced heart failure. This review considers the rationale and evidence for cardiac resynchronization and discusses the indications for its use in clinical practice.
No takes yet. Share an insight, caveat, or question.
Kohli et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: